Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten

JACC Heart Fail. 2024 Apr 7:S2213-1779(24)00263-4. doi: 10.1016/j.jchf.2024.03.009. Online ahead of print.
No abstract available

Publication types

  • Letter